Back
ESC Premium Access

Right atrial volume is the major determinant of tricuspid annulus area in healthy subjects and in patients with functional tricuspid regurgitation due to various etiologies

Session: Poster Session 2 - Assessment and intervention in tricuspid, the no longer forgotten valve
Topic: Tricuspid Valve Disease
Speaker: Associate Professor D. Muraru (Milan, IT)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Associate Professor Denisa Muraru

University of Milan Bicocca, Milan (Italy)
41 presentations
18 followers

13 more presentations in this session

Long-term tricuspid regurgitation progression in patients undergoing combined mitral valve replacement surgery and tricuspid valve repair

Speaker: Doctor O. Itzhaki Ben Zadok (Petah Tikva, IL)

Access
Abstract
Thumbnail

Accuracy of conventional and 3D echo-derived indices of right chamber and tricuspid annulus size to predict severe functional tricuspid regurgitation

Speaker: Doctor A. Guta (Bucharest, RO)

Access
Abstract
Thumbnail

Clinical outcome of isolated tricuspid regurgitation on stable heart failure

Speaker: Doctor Y. Kato (Fukuoka, JP)

Access
Abstract
Thumbnail

Importance to identify the cause of tricuspid regurgitation by 3-dimensional echocardiography in heart failure patients after cardiac implantable electronic device implantations

Speaker: Professor Y. Seo (Nagoya, JP)

Access
Abstract
Slides
Thumbnail

Percutaneous systemic av-valve repair for the treatment of severe tricuspid regurgitation in patients with congenitally corrected transposition of the great arteries

Speaker: Doctor P. Rumpf (Munich, DE)

Access
Abstract
Thumbnail

Access the full session

Poster Session 2 - Assessment and intervention in tricuspid, the no longer forgotten valve

Speakers: Associate Professor D. Muraru, Doctor O. Itzhaki Ben Zadok, Doctor A. Guta, Doctor Y. Kato, Professor Y. Seo...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb